Toray Industries, Inc. announced that its Board of Directors resolved to change the Company?s representative members of the board at the Board of Directors Meeting held on February 10, 2026. Tetsuya Tsunekawa was appointed as Representative Member of the Board Executive Vice President, effective April 1, 2026. Tetsuya Tsunekawa was born on March 28, 1960.
His career includes: April 1984 Joined the Company; January 2004 General Manager, Films & Film Products Research Laboratories; November 2009 General Manager, Advanced Film Technical Dept., Films & Film Products Research Laboratories; June 2012 General Manager, Tsuchiura Plant; June 2014 Vice President (Member of the Board); June 2016 Senior Vice President (Member of the Board); June 2020 Retired from Senior Vice President (Member of the Board) Senior Vice President; June 2022 Senior Vice President; June 2023 Senior Vice President and Member of the Board; April 2025 Executive Vice President and Member of the Board (incumbent). Akihiro Nikkaku was redesignated from Chairman and Representative Member of the Board to Chairman of the Board, effective April 1, 2026. Kazuhiko Shuto was redesignated from Representative Member of the Board Executive Vice President to Member of the Board Executive Advisor, effective April 1, 2026.
Toray Industries Inc is a Japan-based company engaged in the textile business, functional chemicals business, carbon fiber composite materials and other businesses. It has five business segments. Textile segment provides nylon, polyester, cotton, spun yarns, woven and knitted fabrics, nonwoven fabrics, artificial leather and apparel products. Functional Chemicals segment provides nylon, acrylonitrile butadiene styrene (ABS), polybutylene terephthalate (PBT), polyphenylene sulfide (PPS) and other resins products, polyester, electronic information materials and others. Carbon Fiber Composite Materials segment provides carbon fibers, carbon fiber composite materials and carbon fiber molded products. Environment and Engineering segment provides water treatment equipment, information-related equipment, and construction materials. Life Sciences segment manufactures, processes and sells the pharmaceuticals and medical equipment. It also provides analysis, investigation and research services.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
